Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eicosapentaenoic Acid Cerebral Vasospasm Therapy Study (EVAS): Effect of Eicosapentaenoic Acid on Cerebral Vasospasm Following Subarachnoid Hemorrhage

NCT00839449 is registered in ClinicalTrials.gov with Yamaguchi University Hospital as lead sponsor.

NCT NCT00839449
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00839449 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eicosapentaenoic Acid Cerebral Vasospasm Therapy Study (EVAS): Effect of Eicosapentaenoic Acid on Cerebral Vasospasm Following Subarachnoid Hemorrhage
Lead sponsor
Yamaguchi University Hospital
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2004
Completion date
December 31, 2008
Enrollment
200 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral vasospasm, subarachnoid hemorrhage